Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health
Jimini’s $17 million round was from M13, Town Hall Ventures, LionBird, Zetta Venture Partners and…
Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health
Jimini’s $17 million round was from M13, Town Hall Ventures, LionBird, Zetta Venture Partners and OneMind. The post Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health appeared first on MedCity News.
Eli Lilly’s Neuro Prospects Expand to Sleep Science With $6.3B Centessa Acquisition
Centessa Pharmaceuticals’ cleminorexton is part of the orexin agonist drug class, which could introduce a new approach to the treatment of narcolepsy and other sleep disorders. Acquiring Centessa brings Eli Lilly into a group of clinical-stage orexin agonist drug developers that includes Takeda Pharmaceutical, Alkermes, and Eisai. The post Eli Lilly’s Neuro Prospects Expand to…
Device Cleaning Instructions – An Overlooked Safety Risk In Sterile Processing
By Andy Petrovich, National Vice President, Crothall Healthcare & Afif Eschiek, National Director, Crothall Healthcare Many sterile processing departments manage thousands of reusable devices from thousands of manufacturers, each with its unique reprocessing requirements. Hospitals rely on clear instructions for use (IFUs) to safely reprocess these medical devices. Yet inconsistent or impractical instructions continue to…
Healthcare Staff can Maximize the Value of AI with High Performing Endpoints
Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue. The post Healthcare Staff can Maximize the Value of AI with High Performing Endpoints appeared first on MedCity News.
Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate
Here are five things providers should know about concussions. The post Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate appeared first on MedCity News.
Health Care Technology And Tactics For Addressing Gaps In Patient Communication
[Sponsored] Giving patients all the information they need to make informed decisions is crucial. However, common challenges often keep medical teams from achieving that. The post Health Care Technology And Tactics For Addressing Gaps In Patient Communication appeared first on MedCity News.
States Pay Deloitte, Others Millions To Comply With Trump Law To Cut Medicaid Rolls
States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify…
Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
Last August, as part of the federal government’s crackdown on people in the country illegally, the Trump administration sent states the names of hundreds of thousands of Medicaid enrollees with orders to determine whether they were ineligible based on immigration status. But seven months later, findings from five states shared with KFF Health News show…
Healthcare’s Quiet Dependence on the “Possimpible”
By GANESH ASAITHAMBI In an episode of the sitcom How I Met Your Mother (HIMYM), Barney Stinson introduces a fictional word: possimpible. The possimpible combines “possible” and “impossible” and describes the extraordinary achievements by people who refuse to accept conventional limits. In modern healthcare, the possimpible is no longer a joke; it has quietly become…
How did China become a global leader in life sciences?
An NBER working paper by Barwick, Xia and Xia (2026) provides the answer: In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume…We provide strong evidence that China’s rise was primarily driven by the National Reimbursement Drug List (NRDL) reform,…
